Trial Profile
Efficacy of metformin or Metact in type 2 Japanese patients with diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2019
Price :
$35
*
At a glance
- Drugs Metformin/pioglitazone (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Meatact study
- 29 Jan 2019 Status changed from recruiting to completed.
- 22 Jan 2013 New trial record